fixyruw.wordpress.com
The money will be used to place additional orders on existing contracts with vaccine manufacturers includingand , which both have operationd in the Raleigh-Durham area. The governmentt is placing orders for antigenand adjuvant. Antigen is the active ingredient in a vaccines that triggers the immunr system to develop antibodies to fighrt theH1N1 virus. Adjuvant is addefd to boost the immune system and reduce the amount of antigen needed forthe vaccine. The vaccine ingredientd will become a part of thepandemidc stockpile, for use if a vaccination campaign is necessary.
Swis company Novartis (NYSE: NVS), which is buildinh a vaccine manufacturing facility inHollyt Springs, received an order for $346 millioj for antigen and $343.8 millionb for adjuvant. London-based GlaxoSmithKlins (NYSE: GSK), which has its U.S. headquarters in Research Triangle received an orderfor $71.4 million of In addition, received a $61.4 million orderf for antigen, and won a $61 million order for its nasal flu “We are doing our part to be as preparedd as possible for the impact that this infectious diseas e could have on our country,” Health and Humanb Services Secretary Kathleen Sebelius said in a statement.
“Vaccinesa may serve an important role inthat
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment